Combination treatment of multiple sclerosis (MS), other demyelinating conditions and peripheral neuropathy, especially painful neuropathies and diabetic neuropathy

摘要

The present invention relates to a combination useful in treating Multiple Sclerosis, other demyelinating disorders and peripheral neuropathy in a mammal comprising a neurotransmitter-inducing or precursor agent in combination with an (SRI) anxiolytic agent or an antidepressant with improvement in efficiency. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier, a neurotransmitter-inducing or precursor agent, and an SRI antidepressant or anxiolytic agent.